A non-biologically-derived serum formulation is provided for the treatment of skin ailments comprising an anti-fungal agent as an active ingredient, whereby the serum is prepared such that it may be applied topically to a target area for therapy. Preferably, the anti-fungal agent is tolnaftate. In some embodiments, the quantity of anti-fungal is about 1% by weight. Other quantities are contemplated and may be effective as skin care therapy. Other anti-fungal agents are also contemplated.
